Literature DB >> 19184668

Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement.

Julian Little1, Julian P T Higgins, John P A Ioannidis, David Moher, France Gagnon, Erik von Elm, Muin J Khoury, Barbara Cohen, George Davey-Smith, Jeremy Grimshaw, Paul Scheet, Marta Gwinn, Robin E Williamson, Guang Yong Zou, Kim Hutchings, Candice Y Johnson, Valerie Tait, Miriam Wiens, Jean Golding, Cornelia van Duijn, John McLaughlin, Andrew Paterson, George Wells, Isabel Fortier, Matthew Freedman, Maja Zecevic, Richard King, Claire Infante-Rivard, Alex Stewart, Nick Birkett.   

Abstract

Making sense of rapidly evolving evidence on genetic associations is crucial to making genuine advances in human genomics and the eventual integration of this information in the practice of medicine and public health. Assessment of the strengths and weaknesses of this evidence, and hence the ability to synthesize it, has been limited by inadequate reporting of results. The STrengthening the REporting of Genetic Association studies (STREGA) initiative builds on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement and provides additions to 12 of the 22 items on the STROBE checklist. The additions concern population stratification, genotyping errors, modeling haplotype variation, Hardy-Weinberg equilibrium, replication, selection of participants, rationale for choice of genes and variants, treatment effects in studying quantitative traits, statistical methods, relatedness, reporting of descriptive and outcome data, and the volume of data issues that are important to consider in genetic association studies. The STREGA recommendations do not prescribe or dictate how a genetic association study should be designed but seek to enhance the transparency of its reporting, regardless of choices made during design, conduct, or analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19184668     DOI: 10.1007/s00439-008-0592-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  145 in total

1.  Guidelines for human gene nomenclature.

Authors:  Hester M Wain; Elspeth A Bruford; Ruth C Lovering; Michael J Lush; Mathew W Wright; Sue Povey
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

2.  GERBIL: Genotype resolution and block identification using likelihood.

Authors:  Gad Kimmel; Ron Shamir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

3.  Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors.

Authors:  An-Wen Chan; Douglas G Altman
Journal:  BMJ       Date:  2005-01-28

Review 4.  Assessing the quality of case-control association studies on the genetic basis of sepsis.

Authors:  Sally H Vitali; Adrienne G Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

Review 5.  Reliability of statistical associations between genes and disease.

Authors:  Kenneth F Manly
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

6.  Are we ready for genome-wide association studies?

Authors:  Duncan C Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-04       Impact factor: 4.254

7.  Use of methodological standards in diagnostic test research. Getting better but still not good.

Authors:  M C Reid; M S Lachs; A R Feinstein
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

Review 8.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal.

Authors:  J Gelernter; D Goldman; N Risch
Journal:  JAMA       Date:  1993-04-07       Impact factor: 56.272

9.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  A method to address differential bias in genotyping in large-scale association studies.

Authors:  Vincent Plagnol; Jason D Cooper; John A Todd; David G Clayton
Journal:  PLoS Genet       Date:  2007-04-05       Impact factor: 5.917

View more
  67 in total

1.  The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation.

Authors:  Katja Karg; Margit Burmeister; Kerby Shedden; Srijan Sen
Journal:  Arch Gen Psychiatry       Date:  2011-01-03

2.  STREGA: a 'How-To' guide for reporting genetic associations.

Authors:  Thomas J Hudson; David N Cooper
Journal:  Hum Genet       Date:  2009-03       Impact factor: 4.132

Review 3.  Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies.

Authors:  Kalthoum Tizaoui; Anissa Berraies; Besma Hamdi; Wajih Kaabachi; Kamel Hamzaoui; Agnès Hamzaoui
Journal:  Lung       Date:  2014-09-30       Impact factor: 2.584

4.  Genetics and brain morphology.

Authors:  Lachlan T Strike; Baptiste Couvy-Duchesne; Narelle K Hansell; Gabriel Cuellar-Partida; Sarah E Medland; Margaret J Wright
Journal:  Neuropsychol Rev       Date:  2015-03-14       Impact factor: 7.444

5.  Are IL1B, IL6 and IL6R Gene Variants Associated with Anterior Cruciate Ligament Rupture Susceptibility?

Authors:  Ewelina Lulińska-Kuklik; Ewelina Maculewicz; Waldemar Moska; Krzysztof Ficek; Mariusz Kaczmarczyk; Monika Michałowska-Sawczyn; Kinga Humińska-Lisowska; Maciej Buryta; Jakub Chycki; Pawel Cięszczyk; Piotr Żmijewski; Agata Rzeszutko; Marek Sawczuk; Petr Stastny; Miroslav Petr; Agnieszka Maciejewska-Skrendo
Journal:  J Sports Sci Med       Date:  2019-02-11       Impact factor: 2.988

6.  Assessment of systematic effects of methodological characteristics on candidate genetic associations.

Authors:  Badr Aljasir; John P A Ioannidis; Alex Yurkiewich; David Moher; Julian P T Higgins; Paul Arora; Julian Little
Journal:  Hum Genet       Date:  2012-10-25       Impact factor: 4.132

7.  A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement.

Authors:  J A Hollenbach; S J Mack; P-A Gourraud; R M Single; M Maiers; D Middleton; G Thomson; S G E Marsh; M D Varney
Journal:  Tissue Antigens       Date:  2011-11

8.  Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Authors:  Yuanyi Wu; Yong Yang
Journal:  Tumour Biol       Date:  2014-02-07

Review 9.  Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies.

Authors:  Kalthoum Tizaoui; Wajih Kaabachi; Agnès Hamzaoui; Kamel Hamzaoui
Journal:  Cell Mol Immunol       Date:  2014-07-07       Impact factor: 11.530

10.  Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: a genetic association study.

Authors:  Jiri Gallo; Frantisek Mrazek; Martin Petrek
Journal:  BMC Med Genet       Date:  2009-10-27       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.